back to Australia directory
australia clinical guidance

Impetigo (antimicrobial prescribing)

A detailed Australian summary of impetigo (antimicrobial prescribing), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Recognise non-bullous honey-coloured crusts and distinguish bullous disease, eczema infection, herpes and deeper cellulitis, especially in infants. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:National Healthy Skin Guideline

The Bottom Line

  • Recognise non-bullous honey-coloured crusts and distinguish bullous disease, eczema infection, herpes and deeper cellulitis, especially in infants.
  • Exclude scabies in recurrent tropical or remote-community impetigo because simultaneous treatment can be necessary for control.
  • Choose topical or oral antimicrobial therapy from the local pathway according to extent, systemic features, population and resistance pattern.
sources for this section:National Healthy Skin Guideline

Practical clinical workflow

1

Topic-specific assessment action

Recognise non-bullous honey-coloured crusts and distinguish bullous disease, eczema infection, herpes and deeper cellulitis, especially in infants.
2

Topic-specific diagnostic action

Choose topical or oral antimicrobial therapy from the local pathway according to extent, systemic features, population and resistance pattern.
3

Topic-specific management action

Recurrent disease warrants culture when indicated and assessment of household transmission, scabies, skin disease and environmental contributors.
4

Topic-specific follow-through

Avoid sharing towels and keep fingernails short to reduce autoinoculation and household spread.
sources for this section:National Healthy Skin Guideline

Safety boundaries and escalation

  • Bullous disease in a young infant, systemic illness, rapid spread, periorbital disease or post-streptococcal complication concern requires urgent review.
  • Post-streptococcal glomerulonephritis warning signs include dark urine, oedema and reduced urine output and require urgent evaluation.
sources for this section:National Healthy Skin Guideline

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:National Healthy Skin Guideline

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:National Healthy Skin Guideline

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Telethon Kids InstituteNational Healthy Skin Guideline: for the prevention, treatment and public health control of impetigo, scabies, crusted scabies and tinea2nd edition, 2023 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.